Nicolet Advisory Services LLC Trims Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Nicolet Advisory Services LLC decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 31.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,876 shares of the company’s stock after selling 1,342 shares during the quarter. Nicolet Advisory Services LLC’s holdings in HealthEquity were worth $289,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in HQY. Wealthfront Advisers LLC bought a new position in HealthEquity in the fourth quarter worth approximately $10,304,089,000. Vanguard Group Inc. increased its stake in shares of HealthEquity by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock worth $861,256,000 after purchasing an additional 99,624 shares in the last quarter. State Street Corp raised its holdings in HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the period. Geode Capital Management LLC lifted its position in HealthEquity by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company’s stock valued at $200,522,000 after purchasing an additional 10,421 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in HealthEquity by 0.7% during the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock valued at $139,369,000 after purchasing an additional 11,659 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analysts Set New Price Targets

HQY has been the topic of a number of analyst reports. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price target for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Barrington Research reiterated an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. Wells Fargo & Company raised their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Finally, JMP Securities lifted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Buy” and a consensus price target of $112.58.

HealthEquity Trading Down 5.0 %

Shares of HealthEquity stock opened at $78.80 on Friday. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $101.66 and a 200-day moving average price of $96.21. The firm has a market cap of $6.82 billion, a price-to-earnings ratio of 72.29, a PEG ratio of 1.60 and a beta of 0.49.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.